Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Podrobná bibliografie
Hlavní autoři:	Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H
Médium:	Conference item
Vydáno:	2011

Podobné jednotky

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
Autor: Betts, G, a další
Vydáno: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Autor: Griffiths, K, a další
Vydáno: (2013)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
Autor: Gareth Betts, a další
Vydáno: (2012-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
Autor: Griffiths, K, a další
Vydáno: (2011)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
Autor: Stylianou, E, a další
Vydáno: (2015)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
Autor: Poyntz, H, a další
Vydáno: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
Autor: Poyntz, H, a další
Vydáno: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
Autor: Marsay, L, a další
Vydáno: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
Autor: Poyntz, H, a další
Vydáno: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
Autor: Marsay, L, a další
Vydáno: (2013)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
Autor: Christopher J. De Voss, a další
Vydáno: (2025-02-01)

Viral vector delivery of Env trimer immunogens
Autor: Parks CL, a další
Vydáno: (2012-09-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
Autor: Dicks, M, a další
Vydáno: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Autor: Meyer, J, a další
Vydáno: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Autor: Meyer, J, a další
Vydáno: (2013)

Viral vectors as vaccine platforms: from immunogenicity to impact
Autor: Ewer (nee Russell), K, a další
Vydáno: (2016)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Autor: Biswas, S, a další
Vydáno: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
Autor: Poyntz, HC
Vydáno: (2012)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
Autor: Mcshane, H, a další
Vydáno: (2001)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
Autor: Rowland, R, a další
Vydáno: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Autor: Sumi Biswas, a další
Vydáno: (2011-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
Autor: Dicks, M, a další
Vydáno: (2011)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
Autor: Sushmita Kumari, a další
Vydáno: (2022-08-01)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
Autor: Dean, G, a další
Vydáno: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
Autor: López-Camacho, C, a další
Vydáno: (2019)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
Autor: Aiquan Chang, a další
Vydáno: (2022-02-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
Autor: César López-Camacho, a další
Vydáno: (2019-04-01)

Protection by Persuasion: International Cooperation in the Refugee Regime
Autor: Betts, A
Vydáno: (2010)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
Autor: Dean, G, a další
Vydáno: (2014)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Autor: Dicks, M, a další
Vydáno: (2012)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Autor: Sander, C, a další
Vydáno: (2009)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
Autor: Vordermeier, H, a další
Vydáno: (2009)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
Autor: White, A, a další
Vydáno: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
Autor: Vordermeier, H, a další
Vydáno: (2011)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Autor: Goonetilleke, N, a další
Vydáno: (2003)

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles
Autor: Tingfeng Wang, a další
Vydáno: (2024-12-01)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Autor: Stylianou, E, a další
Vydáno: (2019)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
Autor: Dulce Mata-Espinosa, a další
Vydáno: (2023-10-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Autor: Brookes, R, a další
Vydáno: (2008)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
Autor: Aigerim Mailybayeva, a další
Vydáno: (2020-02-01)